Showing results (21-30 of 140) with videos related to
Sort By:
Pageof 14
Science (New York, N.Y.)|December 2, 1988
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitroA M Gewirtz, B CalabrettaBiochimica Et Biophysica Acta|May 12, 2000
Oligonucleotide therapeutics for hematologic disordersN Agarwal, A M GewirtzCancer|June 1, 1981
Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancerA M Gewirtz, E CadmanArchivum Immunologiae Et Therapiae Experimentalis|March 18, 2000
Crosstalk between G protein-coupled receptors and tyrosine kinase signaling: Src take centre stageA Ptasznik, A M GewirtzNature Reviews. Drug Discovery|July 18, 2002
Nucleic-acid therapeutics: basic principles and recent applicationsJoanna B Opalinska, Alan M GewirtzExperimental Hematology|September 1, 1990
Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridizationA M Gewirtz, Y M ShenCritical Reviews in Eukaryotic Gene Expression|January 1, 1996
Gene therapy: basic concepts and recent advancesD L Sokol, A M GewirtzExpert Opinion on Biological Therapy|December 2, 2005
RNA interference for treating haematological malignanciesElizabeth O Hexner, Alan M GewirtzMethods (San Diego, Calif.)|March 19, 1999
Monitoring antisense oligodeoxynucleotide activity in hematopoietic cellsD L Sokol, A M GewirtzPageof 14